WO2024218756 - STABLE PHARMACEUTICAL COMPOSITION OF BUPIVACAINE AND COMBINATIONS THEREOF

National phase entry is expected:
Publication Number WO/2024/218756
Publication Date 24.10.2024
International Application No. PCT/IB2024/053893
International Filing Date 22.04.2024
Title **
[English] STABLE PHARMACEUTICAL COMPOSITION OF BUPIVACAINE AND COMBINATIONS THEREOF
[French] COMPOSITION PHARMACEUTIQUE STABLE DE BUPIVACAÏNE ET SES COMBINAISONS
Applicants **
ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED
Inventors
VALLABHBHAI PATEL, Bhaveshkumar
KINI, Rajesh
SALLLA, Govardhan
Priority Data
202341029074   21.04.2023   IN
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
*
International Searching Authority
*
Applicant's Legal Status
*
*
*
*
*
Entry into National Phase under
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing976
EPO Filing, Examination6968
Japan Filing590
South Korea Filing574
USA Filing, Examination2710
MasterCard Visa
Total: 11,818

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Abstract[English] The present invention relates to a stable pharmaceutical composition of an amide local anaesthetic and other active agent(s). The present invention relates to a stable pharmaceutical composition of bupivacaine optionally meloxicam and other active agent(s) with poly(ortho ester), antioxidant, process of preparation and treatment thereof.[French] La présente invention concerne une composition pharmaceutique stable d'un anesthésique local à base d'amide et d'un ou de plusieurs autres principes actifs. La présente invention concerne une composition pharmaceutique stable de bupivacaïne éventuellement méloxicam et d'un ou de plusieurs autres principes actifs comprenant un poly(ortho-ester), un antioxydant, et un procédé de préparation et de traitement associé.

Rejoining the server...